Inspire Pharmaceuticals, Inc. Posts Narrower-Than-Expected Q4 Loss

March 3 (Reuters) - Inspire Pharmaceuticals Inc (ISPH.O) posted a narrower-than-expected quarterly loss, helped by 36 percent jump in revenue, and expects its cash and investments to provide liquidity through fiscal 2009 and into 2010.

MORE ON THIS TOPIC